Seed VC · USA
Red Tree partners with pioneering entrepreneurs developing first-in-class and best-in-class therapeutics addressing significant unmet needs in oncology, neurology, and immunology. The firm seeks opportunities with the potential to transform people's lives through major leaps forward, not incremental advances.
Business models
biotech_therapeutics, deeptech_ip
Customer segments
Enterprise, Researchers
Geography
US
+ 3 more deals. Score your deck to see the full investment history.
We never publish partner emails directly. Score your deck to unlock contacts for the firms ranked as best-fit.
Red Tree Venture Capital writes first institutional checks where the founder + early product matter more than traction. The seed market is the most dispersed segment of venture; matching to thesis (sector, stage, geography) is where most cold outreach succeeds or fails. VC Boom tracks Red Tree Venture Capital alongside 47,000+ other active investors, ranked weekly by recent-deal momentum, sector concentration, and partner activity.
Drop your pitch. VC Boom scores it on the 8 dimensions VCs read for and ranks the 47,000+ active investors in the database by fit. Red Tree Venture Capital is one of them, and we'll tell you exactly where they sit in your top 100.